Management of hepatocellular carcinoma recurrence after liver transplant is far from perfect

被引：2
|
作者：
Mancuso, Andrea [1 ]
Maringhini, Alberto [1 ]
机构：
[1] Azienda Rilievo Nazl Alta Specializzaz Civ Di Cri, Med Interna 1, Piazzale Leotta 4, I-90100 Palermo, Italy
来源：
AMERICAN JOURNAL OF SURGERY | 2018年 / 216卷 / 02期
关键词：
Hepatocellular carcinoma; Recurrence; Sorafenib; Liver transplant; SORAFENIB TREATMENT; EFFICACY; SURVIVAL; SAFETY; TIME; COMBINATION; EVEROLIMUS;
D O I：
10.1016/j.amjsurg.2017.04.004
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：389 / 390
页数：2
相关论文
共 50 条
  • [1] High trough levels of everolimus combined to sorafenib improve patients survival after hepatocellular carcinoma recurrence in liver transplant recipients
    Nitta, Hidetoshi
    Younes, Aline
    El-domiaty, Nada
    Karam, Vincent
    Sobesky, Rodolphe
    Vibert, Eric
    Coilly, Audrey
    Maria Antonini, Teresa
    De Martin, Eleonora
    Cherqui, Daniel
    Baba, Hideo
    Rosmorduc, Olivier
    Adam, Rene
    Samuel, Didier
    Saliba, Faouzi
    TRANSPLANT INTERNATIONAL, 2021, 34 (07) : 1293 - 1305
  • [2] Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation
    Pelizzaro, Filippo
    Gambato, Martina
    Gringeri, Enrico
    Vitale, Alessandro
    Cillo, Umberto
    Farinati, Fabio
    Burra, Patrizia
    Russo, Francesco Paolo
    CANCERS, 2021, 13 (19)
  • [3] Everolimus Mitigates the Risk of Hepatocellular Carcinoma Recurrence after Liver Transplantation
    De Simone, Paolo
    Precisi, Arianna
    Lai, Quirino
    Ducci, Juri
    Campani, Daniela
    Marchetti, Piero
    Gitto, Stefano
    CANCERS, 2024, 16 (07)
  • [4] Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: A systematic review and meta-analysis
    Mancuso, Andrea
    Mazzola, Alessandra
    Cabibbo, Giuseppe
    Perricone, Giovanni
    Enea, Marco
    Galvano, Antonio
    Zavaglia, Claudio
    Belli, Luca
    Camma, Calogero
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (04) : 324 - 330
  • [5] Management of recurrent hepatocellular carcinoma after liver transplant
    Chok, Kenneth S. H.
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (08) : 1142 - 1148
  • [6] Therapeutic Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma Recurrence After Liver Transplantation: A Systematic Review and Meta-Analysis
    Li, Zhao
    Gao, Jie
    Zheng, ShengMin
    Wang, Yang
    Xiang, Xiao
    Cheng, Qian
    Zhu, Jiye
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2021, 32 (01) : 30 - 41
  • [7] Sorafenib for Hepatocellular Carcinoma Recurrence After Liver Transplant
    Mancuso, Andrea
    TRANSPLANTATION, 2020, 104 (08) : E243 - E243
  • [8] Incidence and Risk Factor of Hepatocellular Carcinoma Recurrence After Liver Transplant: Results From a Single Clinic
    Bolkvadze, Ruslan
    Kashibadze, Kakhaber
    Nakashidze, Merab
    Mikeladze, Lasha
    Beridze, David
    Beridze, Sofo
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2024, 22 (01) : 256 - 262
  • [9] Management of recurrent hepatocellular carcinoma after liver transplant
    Kenneth SH Chok
    World Journal of Hepatology, 2015, (08) : 1142 - 1148
  • [10] Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant
    Mehta, Neil
    Heimbach, Julie
    Harnois, Denise M.
    Sapisochin, Gonzalo
    Dodge, Jennifer L.
    Lee, David
    Burns, Justin M.
    Sanchez, William
    Greig, Paul D.
    Grant, David R.
    Roberts, John P.
    Yao, Francis Y.
    JAMA ONCOLOGY, 2017, 3 (04) : 493 - 500
12345